Content
All Posts > Content under Pharma/Biotech
Vir Biotechnology Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, July 7, 2020 3:11 PM EDT
Vir Biotechnology, Inc., today announced the pricing of its previously announced underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $42.00 per share.
In this article: VIR
This Technology Will Fuel Hundreds Of Billions In Cannabis Profits
Article By:
Michael A. Robinson
Read
Tuesday, July 7, 2020 1:15 PM EDT
Cannabis has come a long way in a short time. The sector has been through its first (but certainly not last) ultra-explosive growth phase.
Novavax Shares Cross $100 Threshold On $1.6B Federal Funding Award For Coronavirus Vaccine
Article By:
Benzinga
Read
Tuesday, July 7, 2020 9:39 AM EDT
Novavax, Inc. shares, which were up about 1,900% year-to-date, are seeing further strength after the company's coronavirus vaccine program was shortlisted by the U.S. government's Operation Warp Speed and awarded $1.6 billion in federal funding.
In this article: NVAX
Vaccinex Provides Update Of Potentially Pivotal SIGNAL Clinical Trial In Huntington’s Disease
Article By:
TalkMarkets Newswire
Read
Tuesday, July 7, 2020 8:34 AM EDT
Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs.
Cannabis Central: Non-Penny Pot Stocks Up On Monday With 2 Of 3 Categories Advancing
Article By:
Lorimer Wilson
Read
Tuesday, July 7, 2020 4:01 AM EDT
To reflect the true health of the cannabis sector the NPSI excludes the 12 non-penny companies in the BioPharmaceutical Category despite the fact that virtually every other cannabis ETF and pot stock tracking index includes at least 1 such company.
In this article: CRLBF, GTBIF, TSNDF, PLNHF, CURLF, TCNNF, ACRGF, AYRWF, CCHWF (NOW CBSTF), SHWZ, JUSHF
Market Briefing For Tuesday, July 7
Article By:
Gene Inger
Read
Tuesday, July 7, 2020 2:18 AM EDT
A golf club putting in a wine cellar, or Planet Hollywood buying an Italian Restaurant chain with tax money is not exactly Government money getting to people who need it most; as was the 'plan'. No wonder they tried to keep it invisible for so long.
The Canadian Cannabis Report - Monday, July 6
Article By:
James Coleman
Read
Monday, July 6, 2020 4:24 PM EDT
The past, present and future of the Canadian cannabis sector, according to my index of 25 stocks.
Pacira BioSciences, Inc. Announces Proposed Offering Of $300.0 Million Aggregate Principal Amount Of Convertible Senior Notes
Article By:
NASDAQ GlobeNewswire
Read
Monday, July 6, 2020 2:12 PM EDT
Pacira BioSciences, Inc., today announced that it intends to offer, subject to market and other conditions, $300.0 million aggregate principal amount of convertible senior notes due 2025.
In this article: PCRX
SPDR Biotech ETF: A Quality Long-Term Bet
Article By:
Sunil Tinani
Read
Monday, July 6, 2020 9:43 AM EDT
I am bullish on SPDR Biotech ETF and consider it as a long-term pick because it is focused on biotech growth stocks. The biotechnology sector has a lot of potential going forward, especially in the post-COVID-19 age.
Increasing Prevalance Of Hypoglycemia Increase The Dextrose Injection Demand
Article By:
Steve Blade
Read
Sunday, July 5, 2020 11:10 PM EDT
The dextrose injection market size is set to register the growing CAGR of 5.2% over the forecast years (2017-2030).
Prep Stock Of The Day: Pfizer
Biotech ETFs To Gain As Coronavirus Vaccine Hopes Strengthen
Article By:
Zacks Investment Research
Read
Sunday, July 5, 2020 1:58 PM EDT
The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to the biotech sector:
Welcome To H2 2020
Article By:
Vivian Lewis
Read
Sunday, July 5, 2020 1:46 PM EDT
Welcome to H2 2020. Think about how hard it is to be a stock-picker in the present situation. It is tough not only for newsletter writers, but also for analysts at brokerages, portfolio advisors, fund managers, and gurus.
7 Monster Stock Market Predictions For The Week Of July 6
Article By:
Michael J. Kramer
Read
Sunday, July 5, 2020 11:46 AM EDT
It will be a typical trading week, and the only thing that matters for the S&P 500 (SPY) is if the futures can push beyond that 3,150 level. Including Thursday, the S&P 500 futures have failed at 3,150 level six times, an adamant resistance level.